Isogenica Ltd – Trademark Portfolio

Entity Type: 99

Isogenica Ltd holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 2 are pending. The owner is based in Cambridgeshire.

The Mansion, Chesterford Research Park

Little Chesterford

Cambridgeshire CB101XL , GB

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Isogenica Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

45
Legal & Security Services (5 filings)

Legal services; security services for the protection of property and individuals

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Isogenica Ltd have?

Isogenica Ltd has 7 U.S. trademarks filed with the USPTO. Of these, 2 pending, 1 abandoned, 1 cancelled.

What trademark classes does Isogenica Ltd file in?

Isogenica Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 45 (Legal & Security Services), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Isogenica Ltd's trademark registration success rate?

Isogenica Ltd has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.